生物技术通报 ›› 2024, Vol. 40 ›› Issue (3): 100-108.doi: 10.13560/j.cnki.biotech.bull.1985.2023-0540

• 综述与专论 • 上一篇    下一篇

增加革兰阴性菌外膜囊泡产量的研究进展

刘灿1(), 闫晓阳1, 曾焱1, 欧祥龙1, 廖永洪1,2()   

  1. 1.西南大学动物医学院,重庆 402460
    2.国家生猪技术创新中心,重庆 402460
  • 收稿日期:2023-05-25 出版日期:2024-03-26 发布日期:2024-04-08
  • 通讯作者: 廖永洪,男,博士,副教授,研究方向:动物细菌病疫苗研究与开发;E-mail: yonghongliao@swu.edu.cn
  • 作者简介:刘灿,男,硕士研究生,研究方向:动物细菌病疫苗研究与开发;E-mail: 1851334119@qq.com
  • 基金资助:
    国家重点研发计划项目(2022YFD1800902);中央高校基本科研业务费-人才引进项目(SWU020020);国家生猪技术创新中心项目(NCTIP-XD/B11);国家生猪技术创新中心项目(NCTIP-XD/C17)

Research Progress in Increasing Yield of Outer Membrane Vesicles from Gram Negative Bacteria

LIU Can1(), YAN Xiao-yang1, ZENG Yan1, OU Xiang-long1, LIAO Yong-hong1,2()   

  1. 1. College of Veterinary Medicine, Southwest University, Chongqing 402460
    2. National Center of Technology Innovation for Pigs, Chongqing 402460
  • Received:2023-05-25 Published:2024-03-26 Online:2024-04-08

摘要:

外膜囊泡(OMVs)是由革兰阴性菌释放的一种囊泡状结构,在革兰阴性菌的生长、感染以及与周围环境交流等过程中发挥重要作用。由于OMVs无活性、不能复制且具有良好的免疫原性,被广泛应用于新型疫苗的研究。但天然OMVs产量低,无法达到规模化生产的要求,OMVs产量提升是OMVs疫苗产业化要解决的关键核心技术问题。本文主要从细菌基因改造、生长培养条件优化和OMVs生产纯化工艺优化3个方面对提升OMVs产量的研究进行综述,以期为OMVs疫苗产业化研究开发提供参考。

关键词: 外膜囊泡, 疫苗开发, 生物发生机制, 产量增加机制

Abstract:

Outer membrane vesicles(OMVs)are vesicle-like structures released by gram-negative bacteria, and OMVs play an important role in gram-negative bacteria growth, infection and communication with the environment. Because OMVs are inactive, non-replicable and possess high immunogenicity, OMVs are widely applied for research and development of novel vaccines. However, the natural OMVs yield is too low to meet scale-up production. To increase OMVs yield is the key technical issue that should be resolved for scale-up production. We mainly review on three aspects for increasing OMVs yield, modification on bacterial genes, optimization on bacterial growth conditions and OMVs production and purification, aiming to provide informative reference for industrial research and development of OMVs vaccine.

Key words: outer membrane vesicles, vaccine development, biogenesis mechanism, yield enhancement mechanism